This article was originally distributed via PRWeb. PRWeb, WorldNow and this Site make no warranties or representations in connection therewith.
Transposagen's extensive experience in the design and production of gene editing tools results in partnership with MCW.
(PRWEB) February 19, 2014
Transposagen Biopharmaceuticals Inc. announced today that it has partnered with the Medical College of Wisconsin (MCW) to provide its gene editing tools for MCWs recent grant from the National Heart, Lung, and Blood Institute to create new genetically modified rat models for studying the genetics of human diseases.
Transposagen has extensive experience in the design and production of gene editing tools, including XTN TALENs for the production of genetically modified rats and other organisms. Through its premium gene editing tools programs, which include cell-based activity testing, Transposagen provides partners with a guarantee of successful gene modification projects. Recently, one of Transposagens pharmaceutical partners successfully genetically modified a target gene after 10 years of failed attempts using TALENs or Zinc Finger Nucleases (ZFNs) from other providers.
In addition to high efficiency gene editing nucleases, Transposagen holds exclusive licenses and patents to the piggyBac Gene Modification System, which can be used in combination with site-specific nucleases, such as XTN TALENs and CRISPRs for Footprint-Free Gene Editing in cells and animals. The Footprint-Free Gene Editing System is the worlds only source for clean editing down to a single base-pair with no unwanted mutations and the ability to select for rare events. Alternative engineering systems, such as CRE/lox and Flp/FRT, leave behind mutations in the genome that can result in gene silencing and toxicity.
Transposagens partnership with MCW is another example of the use of its industry-leading gene editing technology in academic labs around the world. Transposagen is actively seeking partnerships for gene editing projects and can help academic researchers receive grants, perform successful research and get published in top journals. Transposagens gene editing technology is also used by the majority of the top pharmaceutical companies for the creation of custom cell lines and animal models.
For the original version on PRWeb visit: http://www.prweb.com/releases/2014/02/prweb11593628.htm
Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact firstname.lastname@example.org.